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Lichen planus is characterized by a dense infiltrate ofT 
lyxnphocytes at the derIDoepiderlDal junction. To de-
tertnine the phenotypic and functional characteristics 
of the infiltrating IYIDphocytes, T -cell lines froID nor-
mal and lesional skin from the same patients with li-
chen planus were established by culture with interleu-
kin 2 followed by stimulation every 14 d with 
phytohemagglutinin and irradiated allogeneic feeder 
cells. Resultant T -cell lines were immunophenotyped 
by staining with monoclonal antibodies and their reac-
tivity tested by deterIDining their cytolytic activity to 
selected targets. T -cell lines from 13 lesional and nine 
normal biopsy specimens were studied. 
T-cell lines from normal skin were 61% CD4+ and 
32% CD8+, whereas lines froID lesional skin had signif-
L ichen planus (LP) [1 ,2] is characterized by a dense infil-trate of lymphocytes along the dermoepidermal junc-tion and by destruction and vacuolar degeneration of basal layer keratinocytes [3]. A large percentage of the infiltrating cells are T lymphocytes, many of which are 
intimately associated with the dermoepidermal junction and extend 
between basal cells [3 ,4] . 
Some cases of LP or LP-like (lichenoid) eruptions have been 
linked to exposure to contact allergens or to ingestion of certain 
drugs [1,2]. The association ofLP to topical antigens and to ingested 
drugs suggests that reactivity to antigens present in the skin or cross 
reactivity directed at skin tissues may be responsible for the develop-
ment of the disease. Idiopathic LP may result from a similar mecha-
nism involving abnormal antigen expression or an abnormal re-
sponse of the skin immune system to normal1y expressed antigens of 
the epidermis. 
Several lines of evidence suggest an autoimmune mechanism. 
Epidermotropic, major histocompatibility c?mplex (MI:IC). class 
II - specific, auto reactive T cells produce a histopathologic picture 
indistinguishable from LP when injected into the footpads of syn-
geneic mice [5]. Patients with chronic graft-versus-host disease may 
present with a skin disease clinical1y and histopathologically similar 
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icantly fewer CD4+ cells (13%) and more CD8+ cells 
(62%). T-cell lines froID lesional skin contained a dis-
tinctive population of yc5 T cells that was rarely present 
in lines derived froID normal skin. We were able to 
culture yc5 T cells out of the lesional skin of 12 of 13 
patients. In these 12 patients, lesional T -cell lines were 
17% yc5+ (range 2% to 47%). Only one T-cell line from 
norlDal skin contained significant nUIDbers of yc5 T 
cells. The yc5 population from lesional skin was COID-
monly VcJ1JcJl+. These results suggest that CD8+ and 
TCR yc5+ T lymphocytes may be involved in the devel-
opment or the maintenance of lichen planus. Key 
words: T lymphocytes/autoimmunitY/I'd cells.] Invest Der-
matoI103:347-351,1994 
to typical lichen planus [1,2,6] . Therapies designed to suppress im-
mune responses (e.g., corticosteroids, psora len plus ultraviolet A, or 
cyclosporine) are commonly effective in treating LP [7,8] . Taken 
together, these data suggest that lichen planus may be a T-cell-
mediated autoimmune disease and that the infiltrating T lympho-
cytes recognize and respond to self antigens or newly expressed 
antigens present in the epidermis. 
In an att~mpt to investigate the rol e of T lymphocytes in the 
pathogeneSIs of LP, we cultured Infiltrating T lymphocytes from 
skin biopsies obtained from lesional and clinically uninvolved skin 
oflichen planu~ patie~ts. Resultant T -cell lines were immunophen-
otyped by sta1l1111~ ~Ith m~noclonal antibodies and their reactivity 
tested b'y deter~un1l1g their cytolytic activity to selected targets. 
T-cell hnes denved from lesional skin were predominantly CD8+ 
and con~ai~ed a dis.tinctive popnlation of y!5 T cells that was rarely 
present III hnes denved from normal skin. Our results indicate that 
CD8+ T cells are the predominant cell infiltrating the skin in LP 
and suggest that y!5 T cells may playa role in the pathogenesis or the 
maintenance of lichen planus. 
MATERlALS AND METHODS 
Patients Five-millimeter skin biopsy specimens from normal and lesional 
skin and 30 cm3 of peripheral blood were obtained from each of 13 untreated 
volunteer patients with lichen planus. The patients involved in the study 
presented with typical LP lesions consisting of polygonal, violaceous, flat-
topped papules with Wickham's striae. Each patient'S diagnosis was con-
firm~d by ~istopathology showing a band-like infiltrate at the dermoepider-
mal JunctlOn, damage to the basal cell layer, irregular acanthosis, focal 
hypergranulosis, and hyperkeratosis [3] . Lesional skin biopsy specimens 
were obtained from three patients with untreated lupus erythematosus as 
additional controls. Two patients had discoid lupus without evidence for 
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Table I. Antibodies Used 
Antibody 
LEU-6 
12F6 
OKT4 
OKT8 
PanTCRa/3 
TCR01 
BB3 
OV2(a) 
A13 
orCSl 
TIyA.l 
TCR-y/a-l 
LFA-la 
LFA-1/3 
N KH-1 
IL-2R 1 
Specificity 
CDl 
CD3 
CD4 
CD8 
TCRa/3 
TCRyo 
V.2 
V.2 
V.l 
Vol]"l 
Vl-
TCRya 
LFA-la 
LFA-1/3 
NK cells 
IL-2 receptor 
Source 
Becton-Dickinson, San Jose, CA 
Man-Sun Sy, Harvard Medical School, 
Boston, MA 
American Type Culture Collection 
(ATCC) 
ATCC 
T Cell Diagnostics, Cambridge, MA 
T Cell Diagnostics 
Franco Pandolfi, Viale dell' Universita,' 
Roma,ltaly 
T Cell Diagnostics 
Franco Pandolfi 
T Cell Diagnostics 
Coulter Immunology, Hialeah, FL 
Becton-Dickinson 
Becton-Dickinson 
Becton-Dickinson 
Coulter 
Coulter 
systemic involvement and one patient had . systemic lupus erythematosus 
with discoid lesions. Patients' informed, wrttten consent was obtamed and 
the protocols were approved by human studies committees of Beth Israel and 
Massachusetts General Hospitals. 
T-Cell Lines Derived from Skin T-cell lines were derived from each 
skin biopsy specimen as previously described [9]. Half of each biopsy speci-
men was cut into small fragments and cultured in one well of a 24-well plate 
in RPMI medium containing 5% pooled, heat-inactivated , human serum, 50 
Itg/ml of gentamicin, 1 mM L-glutamine, and 50 units/ml of recombinant 
interleukin 2 (IL-2) (Collaborative Research Incorporated, Cambridge, 
MA). After 2-3 d in culture, the cells were stimulated with 1 p g/ml of 
phytohemagglutinin (PHA) (Wel1come Diagnostics, Dartford, England) 
and rrradiated (3000 rads) allogeneic peripheral blood mononuclear cells. 
PHA and irradiated feeder cell stimulation were repeated every 14 d. 50 
U/ml of IL-2 were used throughout the culture period. T-cell lines were 
established from peripheral blood mononuclear cells fro m three healthy 
volunteers to serve as controls for assessing the effects of the cell culture 
conditions. 
Monoclonal Antibodies (MoAb) Resultant T-cell lines were stained 
with a panel of MoAb (Table I). Goat anti-mouse IgG F(ab')2-fluorescein 
isothiocyanate (FITC) MoAb (Cappel, Durham, NC) was used at a final 
di lution of 1 : 80 as second step with the unconjugated MoAbs. The controls 
used were the respective isotype for each MoAb (obtained from Coulter 
Corporation, Hialeah, FL). 
Immunophenotyping After 15 to 21 d in cultu.re a portion of ~ach 
skin-derived T-cell line was centrifuged over a Flcoll-Paque gradient, 
washed twice in phosphate-buffered saline (PBS) with 0.1 % bovine serum 
albumin and once in PBS with 0.1 % BSA and 0.1 % sodium azide. Cel ls 
(5 X 105) were incubated for 30 min on ice with a first-step MoAb, washed 
three times in PBS with BSA and sodium az ide and incubated another 30 min 
with a second-step MoAb, washed, and fi xed in 1 % paraformaldehyde. For 
two-color staining,S X 105 cel ls were incubated for 30 min on ice with 
phycoerythrin (PE) -conjugated T-cell receptor (TCR) 01 (Becton Dickin-
son, San Jose, CA) and FITC-conjugated orCSl (specific for VOl) or 
TCRya2 (specific for V 02) (T-Cel l Diagnostics, Cambridge, MA), washed, 
and fixed as described. Flow cytometry was performed on a FACscan (Bec-
ton-Dickinson, San Jose, CA). Gating of SSC and FSC for viable cells was 
performed as described [10]. Five thousand cells were analyzed for each 
sample. 
EBV Transformed Mononuclear Cells Peripheral blood mononuclear 
cells were isolated from heparinized blood by density-gradient centrifuga-
tion over Ficoll-Paque (Phannacia LKB Biotechnology Inc., Sweden). T he 
cells were washed twice in PBS containing 0.1 % BSA and pelleted. The 
pellet was then incubated 90 min at 37" C in the presence of 1 to 2 ml of 
Epstein-Barr virus containing supernatant obtained fro m B95-8 cells 
(American Type Culture Collection, Rockville, Maryland). The cells were 
resuspended in RPM] medium containing 10% fetal bovine serum, 50 J1.g/ 
ml of gentamicin, 1 mM L-glutamine, and 1 pg/ml of cyc1osporin A (Sandoz 
Pharmaceutical Corp., Hanover, NJ) and cultured at 37 "C in 5% CO2 in a 
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Figure 1. Flow-cytometry histograms of T-cell line derived from 
normal (A) or lesional (B) skin of patient 3 stained with MoAbs to 
CD4, CDS, or TCR yb. The T-cell lines from patient 3 were stained wirh 
MoAbs OKT4 (CD4), OKT8 (CD8), and TCR-yo-1 (pan TCRyO) and 
analyzed by cytofluoremetry. Five thousand cells were analyzed per sample. 
Isotype controls appear in white. 
24-well plate at a concentration of2 X 106 per wel l. After about 3 weeks in 
culture, transformed cells were passed into flasks and maintained in complete 
RPMl contain ing 1 % Hepes buffer (Irvine Scientific, Santa Ana, CA) with-
out cyclosporin A. 
Cytolytic Assay Cytolytic activ ity was determined using a standard 4-h 
chromium release assay [11] . T-cell lines were collected 8 -to d after the last 
PHA stimulation, centrifuged over Ficoll-Paque gradients, washed three 
times, and resuspended at 2 X 106/ml. In some experiments, T-cell lines 
were cultured ill vitro with irradiated autologous or allogeneic EBV -trans-
formed B cells for 5 d prior to collection for cytolytic T-cell assays [11 ]. 
K562 (natural killer [NK) cell targets), Daudi (lymphokine activated killer 
[LAK] cell targets), and EBV -transformed B cells were labeled with 51Cr for 
90 min at 37"C and washed to remove excess chromium. Targets were 
plated in 96-well round-bottom plates at 2000 targets per well in a final 
volume of 200 J1.1/well. E/T ratios were 100 : 1, 50: 1, 25: 1, and 12.5 : 1. 
Positive controls for cytolytic assays consisted of effector cells and K562 or 
Daudi cultured in the presence of PH A (lectin-mediated killing). After 4 h, 
plates were centrifuged and 100 pi of supernatant removed and counted in a 
gamma counter. Percent lysis was calculated as described [11). 
RESULTS 
T-Cell Lines Were Established from 13 Lesional Biopsy 
Specimens T -cell lines were established from 13 lesional biopsy 
specimens from LP patients and in nine of the patients lines were 
established from normal skin biopsy specimens from the same pa-
tients. Normal skin biopsies were not done in two patients and T 
cells did not grow out of the normal skin bio psy specimen in two 
patients. A significantly greater number of cells migra ted &om the 
lesional skin fragments than from the normal skin fragments in the 
first 2 d in culture. After the first PHA stimulation, cultures of 
T -cell lines from normal and les ional skin contained 0 .5 to 1 X 107 
cells and 1 to 2 X 107 cells, respectively. 
Immunophcnotypc of T-Cell Lines Established from Nor-
mal and Lesional Skin Greater than 93% of the cells derived 
from normal and lesional skin biopsies expressed CD3 and were 
therefore T cells. T-cell lines derived from normal skin w ere 61 % 
CD4+ and 31 % CD8+. The proportion of CD4+ cells was signifi-
cantly decreased and the proportion of CD8+ cells w as increased in 
T -cell lines derived from lesio nal skin (1 2% and 63%, respectively) 
(Fig 1 and Table II). 
T-cell lines derived from lesio nal skin contained a population of 
yo cells that were rarely observed in significant numbers in T-cell 
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Table II. Staining for CD4, CDS, yo, and NKH-l 
Percene Positive Cells' 
C04 C08 yo NKH-1 
Patient N L N L N L N L 
1 48 33 42 41 0 7 NP' NP 
2 57 2 0 78 0 13 NP 40 
3 69 13 26 37 3 34 NP NP 
4 78 3 25 29 7 47 8 42 
5 79 68 5 22 1 3 NP NP 
6 10 3 85 73 0 27 4 21 
7 96 0 0 86 1 2 4 31 
8 53 6 NO' 84 0 0 NO NP 
9 NO 0 NO 66 NO 12 NO NO 
10 NG J 8 NG 71 NG 23 NG 5 
11 NO 14 NO 67 NO 6 NO 9 
12 NG 3 NG 78 NG 2 NG 70 
13 NO NP NO NP 0 25 1 35 
Meanb I 61 13 26 61 15 4 32 
SD 26 20 30 22 2 15 3 21 
• T -cell lines derived from normal (N) or lesional (L) skin were stained with mono-
lonal antibodies to C04, COS, TCR yo, or NKH- t after two cycles of stimulation. ~he percentage of each cell line that stained positively was determined by flow cytome-
try. Five thousand cells were analyzed for each sample. . . 
• The statistical Slgntficance of ddferences between means was deterDuned by usmg 
paired t tests. The differences in means between normal and lesional T cells were 
significant for C04, yo, and NKH- t (p = 0.005, O.Ot , and 0.006, respectlvely), shown 
in boxes. 
, Some patients did not have biopsies of normal skin (NO). 
I Some normal T-cell lines did not grow (NG). 
, A lesional ce ll line of one patient was not stained for C04 or COS (NP) and several 
normal and lesional cell lines were not stained for NKH-l because the antibody was not 
available or there were too few cells at the time of staining. 
lines from normal skin. We were able to culture yoT cells out of the 
lesional skin of 12 of 13 patients. In these 12 patients, lesional T-cell 
lines were 17% yo+ (range 2% to 47%). In contrast, only four of nine 
cell lines derived from normal skin had measurable yo+ cells. The 
percentage of yeS T cells in these four cell lines was significantly 
lower (3%, range 1 % to 7%) (Fig 1 and Table II). In one patient 
(patient 4 in Table II), the T -cell line derived from normal skin was 
7% yl5+. This patient had the highest percentage of yo T cells in 
lesional skin (47%) and had diffuse disease that made it difficult to 
distinguish normal from lesional skin. 
The percentage of lesional skin-derived T cells expressing NK 
cell antigen (NKH-1) was consistently higher than the percentage 
in T -cell lines from normal skin . Thirty-two percent of the T cells 
in lines derived from lesional skin expressed NKH-l antigen. In 
contrast, on ly 4% of the T cells in lines from normal skin exhibited 
weak NKH-1 expression (Table II). 
Two-color immunofluorescence staining with PE-yeS (which rec-
ognizes all yeS T cells) and FITC-c>TCSl (which recognizes all 
VolJ,51 + T cells) or FITC-TCR02 (which recognizes V,52+ T cells) 
demonstrated that yeS cells in many of the T -cell lines from lesional 
skin expressed Vol (Fig 2). Vol expressing cells comprised from 3% 
to 100% of the yeS T cells in these cell lines (Table III). Vol was 
expressed by at. least 48% of .the yeS cells in six of the 11 tested 
lesional T -celllll1es that contallled yO T cells. Only one T -celllll1c 
tes ted had detectable V,2+ cells. Consequently, approximately half 
of the T-cell lines established from patients with LP contain the 
Vol subset. The yeS T-cell population in LP rare ly contains V,2. 
To determine whether V ol+yO T cells would be preferentially 
cultured from another inflammatory skin disease or from peripheral 
blood, T-cell lines were established from three patients with histo-
pathologically confirmed lupus erythematosus and from peripheral 
blood lymphocytes of three normal healthy adults. A substantial 
population of yo T cells was present in one of three T-cell lines 
derived from lupus lesions and in one of three T-cell lines derived 
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Figure 2. Flow-cytometry contour histograms oflesional T -cell line 
from patient 1 stained with yJ MoAbs. Two-color immunofluorescence 
staining of the T-cell line derived from lesional skin of patient 1 was per-
formed with phycoerythryn-conjugatcd TCROI (pan TCR yO) (y axis) and 
FITC-tITCSI (VJ1/ ] Jl) (x axis) and analyzed by two-colorcytofluoremetry . 
The percent positive cells is indicated. 
from norma l peripheral blood. The )'0 T cells predominantly ex-
pressed Vo2 (Table IV). 
Ninety-five percent of the cells from normal and lesional skin -
derived T-cell lines expressed the a and the fJ chains of LFA-l aJld 
greater than 80% of the cells were IL-2R1 +. N one of the cell lines 
had detectable Leu-6+ (CD1+) cells. 
cytolytic Activity ofT-Cell Lines Derived from Normal and 
Lesional Skin Animal models of LP suggested that the disease 
may be mediated by class II autoreactive T cells [5]. W e therefore 
tested the ability ofT-ceil lines established from involved and unin-
volved skin to specifically lyse autologous EBV -transform ed B cell s 
or selected allogeneic targets. 
One of six lesional T-cell lines and one offive normal T-cell lines 
lysed autologous EBV-transformed B cells. The percent lysis by the 
lesional T -cell line and the normal T -cell line that lysed autologous 
EBV-transformed B cells were 13/ 18/ 16/ 33 and 8/ 15/ 19/27 at 
effector-to-target ratios of 12.5 : 1, 25: 1, 50 : 1, and 100 : 1, respec-
tively. Lectin-mediated lys is ran ged frol1149 % to 90% at th ese effec-
Table III. Percentage of yeS T cells Expressing the V 01 
Phenotype 
Patient Percent" 
1 92 
2 0 
3 3 
4 87 
5 NOb 
6 100 
7 97 
8 Noneb 
9 0 
10 13 
11 0 
12 100 
13 48 
• T-cclilines froll1lesional skin were stained with MoAb ro TCR yo and V, tl. ! and 
the percentage of )'o T cells that express V dt was determined. Five thousand cells were 
analyzed for each sample. 
• NO, not done; none, the patient had no 1'0 T cells. 
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Table IV. yb T-Cell Populations in Other T-Cell Lines 
Percent Positive' 
Group Patient yc5 VJ1 VJ2 
1 15 0 13 
Peripheral blood lymphocytes 2 2 0 1 
3 2 0 0 
1 0 0 0 
Lupus erythematosus 2 8 1 5 
3 0 0 0 
• T-cell lines were established as described and stained with MoAb specific for yJ, 
V 61, and V 62. The percentage of each line that stained positively was detennined by 
flow cytrometry. Five thousand cells were analyzed for each sample. 
tor-to-target ratios. T-cell lines from both normal and lesional skin 
lysed K562 (NK cells targets). One of three normal cell lines and 
three of five lesional cell lines lysed Daudi (LAK cell targets). There 
were no consistent or significant differences in the percent lysis of 
these targets between normal and lesional T-cell lines . 
DISCUSSION 
We investigated the role of infiltrating lymphocytes in lichen 
planus by studying T -cell lines established from normal and lesional 
skin of patients with LP. T -cell lines from normal and lesional skin 
had significant differences in the proportion of CD4+ and CD8+ 
cells. T-cell lines from normal skin contained a predominance of 
CD4+ cells and fewer CD8+ cells, whereas the T-cell lines from 
lesional skin contained a predominance of CD8+ cells and few 
CD4+ cells. These results are similar to T-cell lines derived from 
patients with oral lichen planus [12]. 
There are two likely explanations for differences in the propor-
tion of CD4+ and CD8+ cells in T-cell lines from normal and 
lesiqnal skin. First, activated T cells present in vivo in lesions of LP 
may be preferentially expanded under the conditions used to derive 
T -cell lines. Skin biopsy specimens were initially incubated with 
IL-2 alone for 2 or 3 d. IL-2 preferentially expands activated, IL-2 
receptor-positive cells [13]. Activated CD8+ may, therefore, pre-
dominate in lesions of lichen planus but not in normal skin. 
A second explanation for differences in the proportion of CD4+ 
and CD8+ cells in T -cell lines from normal and lesional skin is that 
the relative proportion of CD4+ and CD8+ cells may be different ill 
situ . Using immunohistochemical staining of LP lesional skin, we 
found that CD8+ cells predominated in all of the lesions studied 
(data not shown). The majority of several immunohistochemical 
studies of lichen planus indicated that the proportion of CD8+ cells 
is increased in lichen planus [4,14-16]. De Panfil is found that T 
lymphocytes in early lesions were predominantly CD4+ whereas T 
lymphocytes in late lesions were predominantly CD8+ [16]. The 
majority of T lymphocytes in normal skin are CD4+ [3]. In our 
study the majority of patients had LP for more than a month and the 
areas sampled were late lesions. Therefore, the decrease in the rela-
tive proportion of CD4+ cells and the increase in the proportion of 
CD8+ T cells in T -cell lines from lesional skin is consistent with our 
immunohistochemical results and previously published immuno-
histochemical results and with the age of the lesions [4,14-16]. 
T -cell lines from lesional skin contained a population of yOT cells 
that were rarely present in T-cell lines derived from normal skin. 
The yo T-cell populations were found in 12 of 13 cell lines estab-
lished from lesional skin. This result suggests that TCR yo cells play 
a role in the pathogenesis or the maintenance of the disease. 
TCR yO cells represent a small fraction of T cells in human pe-
ripheral blood (5 - 9%) [17 - 19]' These yb T cells are primarily of 
the Vy2/Vij2 subset (Seidman nomenclature [17 - 19]) . However, in 
the human fetal thymus, TCR yo cells of the Vol subset represent 
70 - 80% of the CD3+ cells [19]. TCR yo cells represented 7 - 9% of 
CD3+ cells in normal human dermis [20,21]. 
Our results indicated that T -cell lines established from the lesions 
of LP contain a population of yo cells that are not commonly found 
in normal skin or in mature peripheral lymphoid organs. As demon-
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strated by immunophenotyping, the yO T cells observed in approxi-
mately half of the lesional cell lines stained predominantly with 
MoAbs specific for V ol (A13) and Vij1]ol (OTCS 1) but failed to stain 
with a MoAb specific for Vy2 (TiyA.l). The TCR yo cells observed 
in these T-cell lines were, therefore, of the V o1]ol phenotype, a 
non-disulfide-linked form of the TCR yo. We have not yet identi-
fied the Vy segment of lesional ye) T cells. 
There are three possible explanations for the observation that 
significantly more yo T cells are present in lesional cell lines. First, 
activated ye) T cells may be present in Il illO in lesions of LP, and these 
activated cells are preferentially expanded under the conditions used 
to derive T -cell lines. In support of this possibility is the observation 
that yo T cells were detected in few T -cell lines derived from normal 
skin in spite of reports that yo T cells represent 7% to 9% of the 
CD3+ cells in normal human dermis [20,21]' yo T cells may not 
have been expanded from normal skin because they are not activated 
il1l1illO in normal skin and therefore are not maintained or stimulated 
by the initial culture period with only IL-2 . However, subsequent 
stimulation with PHA and feeders should lead to polyclonal activa-
tion of all T cells including yo T cel ls if they were maintained in the 
initial culture period. 
A second possibility is that yO cells are present in larger numbers 
in lesional skin than in normal skin. This possibility would be sup-
ported by finding increased numbers of yo cells in the dermal infil-
trate in immunohistochemically stained sections of LP. At least 
three studies investigating yo T cells in inflammatory skin diseases 
have been published [22 - 24]. In one of these studies, yoT cells were 
rarely seen in four LP patients studied [23] . In another study, yo T 
cells comprised 15% of infiltrating T cells in one of three patients 
studied [22] . In the third study, yo T cells comprised 10% to 20% of 
T cells in the lichenoid infiltrate of one patient with LP [24]. W e 
performed immunohistochemical staining of several specimens a 
portion of which were also cultured as described. yo T cells were 
infrequently observed in the infiltrate. However, yJ T cells were 
also only a small proportion of the T-cell lines established from 
those biopsies. 
Finally, the observed expansion of yo cells in lesional cell lines 
may be a consequence of the culture conditions. yo T cells are 
known to proliferate in the presence of combinations of cytokines 
[25]. The cytokines present when T cells from lesions are stimulated 
with PHA and irradiated feeder cells may favor expansion of yo T 
cells. These conditions may not exist during establishment of nor-
mal skin cell lines. Serial immunophenotyping at greater than 3 
weeks in culture failed to document yo cell expansion in the normal 
T cell lines. Even prolonged culture failed to expand yo cells in 
T-cell lines from normal skin. In contrast i'O T cells were often 
expanded in cultures from lesional skin. 
One of three T -cell lines derived from untreated lupus lesions and 
one of three T-cell lines derived from normal peripheral blood 
contained a substantial population of yo T cells. The yo T cells 
predominantly expressed V o2. Thus the ability to establish T-cell 
lines containing populations of yo expressing T cells is not unique to 
lesions of lichen planus. Whether expression of Vol by T cells in 
T -cell lines established from lesional skin of inflammatory disease is 
limited to specific diseases will require further study. 
Data from both animal and human studies support the hypothesi 
that LP is an autoimmune disease mediated by T cells. Saito et al 
produced a series of autoreactive, la-specific T-cell clones in mice 
and found that some of the clones migrated to the epidermis when 
they were injected into the footpads of syngeneic mice. These epi-
dermotropic, la-specific, autoreactive T-cell clones produced a his-
tologic picture indistinguishable from lichen planus when they 
were injected into the footpads of syngeneic mice [5]. Both the 
band-like infiltrate and destruction of basal layer keratinocytes 
characteristic of lichen planus were reproduced. LP in humans may 
also be mediated by class II specific, autoreactive T cells because the 
epidermis contains la+ Langerhans cells and there is a strong corre-
lation between the presence of HLA-DR+ keratinocytes and the 
intensity of the dermal infiltration in lichenoid diseases [26]. 
We therefore tested whether lesion-derived T cells would lyse 
class II - positive, syngeneic targets. One of six lesional T-cell lines 
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nd one of five normal T -cell lines lysed class 11+, autologous EBV-~ransformed B cells. These results suggest that the lesional T -cell 
opulations in most cases of LP are not class II autocytolytic. 
p Lichen planus is characterized not only by a prominent dermal 
lymphocytic infiltrate in close apposition to the epidermis but also 
by vacuolar degeneration of basal keratinocytes [3] . We therefore 
sought to determine whether lesional T-cell lines would lyse auto-
logou s normal ~nd lesional keratinocytes. Keratinocytes . from le-
sional biopsies did not grow well enough to perform expenments 11l 
most cases. However, in one experiment, w here autologous lesional 
keratinocytes were available to use as targets in cytolytic T lympho-
cyte assays, autologous lesional keratinocytes were lysed by lesiona l 
but not normal-skin - derived T-cell lines. These preliminary ex-
periments suggest that lesional T cells are autoreac~ive a~d mediate 
damage to lesiona l kera~l1locytes. LesJOnal T-cell hnes did not lyse 
allogenic, normal. kera tll1ocytes. . . . 
T _ceJllines derived from both normal skll1 and lesJOnal skll1 con-
sistently lysed K56~ (NK cell. targets) . There w~re no ~onsistent 
differences in the abd lty of lesJOnal and normal sklll-denved lym-
phocytes to lyse K562 even though the percentage oflesional skin-
derived T cells expressing NK cell antigen (NKH-l) was cOllSist-
endy higher than T ce ll ~ derived.from nO.rmal skin (3.2% a.nd 4%, 
respectively). Thus, an eightfold Illcrease III NK cells Identified by 
surface phenotyRe is not accompanied b~ a discernible increase in 
lytic activity agalllst NK cell targets . ThiS lack of correlatIOn may 
have many causes but cannot be entirely explained. First, NKH- l 
may not be entirely specific for NK cells .(i.e., ~o.me cells staining 
positively with NKH-l may not have lytic actlVlty) [27]. Second, 
the number ofNKH-l + cells present in normal skin - derived T-cell 
lines may be sufficient to produce maximal lysis of K562 and the 
additional number present in lesional skin- derived lines produce no 
additional lysis. This hypothesis seems unlikely, because there was 
no difference even at low EIT ratios . Third, NKH-l - negative cells 
in normal skin - derived T -cell lines may have lytic activiry against 
K562. 
In summary, T-cell lines derived from lesions of lichen planus 
had significantly fewer CD4~ cells and more CD8~ cells than T -.cell 
lines derived from normal skill from the same patients. T-cell hnes 
from lesional skin contained a distinctive population of yc5 T cells 
that was rarely present in lines derived from normal skin. These 
results suggest that CD8+ and TCR yc5+ T lymphocytes are involved 
in the development or the maintenance of lichen planus. 
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